We are live on ! Find out more
CC

Centiva Capital Portfolio holdings

AUM $11.5B
1-Year Est. Return 31.97%
This Fund
S&P 500
This Quarter Est. Return
+15.12%
1 Year Est. Return
+31.97%
3 Year Est. Return
+65.13%
5 Year Est. Return
+86.06%
10 Year Est. Return
AUM
$2.05B
AUM Growth
+$409M
Cap. Flow
+$70.8M
Cap. Flow %
3.46%
Top 10 Hldgs %
28.16%
Holding
994
New
395
Increased
156
Reduced
153
Closed
202

Sector Composition

Rank Sector Weight
1 Miscellaneous 81.47%
2 Communication Services 3.99%
3 Healthcare 3.67%
4 Consumer Discretionary 3.11%
5 Technology 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
151
CALL
American International
AIG
$40.1B
$2.69M 0.13%
52,300
-23,600
-31% -$1.25M
LOGM
152
DELISTED
LogMein, Inc.
LOGM
$2.68M 0.13%
+31,296
New +$2.32M
VRTX icon
153
PUT
Vertex Pharmaceuticals
VRTX
$139B
$2.65M 0.13%
12,100
-400
-3% -$81K
IONS icon
154
CALL
Ionis Pharmaceuticals
IONS
$10.4B
$2.6M 0.13%
43,100
EA
155
CALL
DELISTED
Electronic Arts
EA
$2.57M 0.13%
+23,900
New +$2.37M
LATNU
156
DELISTED
Union Acquisition Corp. II Units containing one ordinary share and one redeemable warrant
LATNU
$2.56M 0.13%
+250,000
New +$2.52M
MDCO
157
PUT
DELISTED
Medicines Co
MDCO
$2.55M 0.12%
+30,000
New +$2M
SFTW.U
158
DELISTED
Osprey Technology Acquisition Corp. Units, each consisting of one share of Class A Common Stock and
SFTW.U
$2.54M 0.12%
+250,000
New +$2.51M
IBM icon
159
CALL
IBM
IBM
$225B
$2.53M 0.12%
19,769
+3,661
+23% +$476K
FXI icon
160
iShares China Large-Cap ETF
FXI
$4.2B
$2.5M 0.12%
57,208
-71,856
-56% -$3M
UNH icon
161
UnitedHealth
UNH
$355B
$2.5M 0.12%
8,487
-6,623
-44% -$1.73M
GM icon
162
PUT
General Motors
GM
$75.6B
$2.49M 0.12%
68,000
+56,800
+507% +$2.06M
KMB icon
163
CALL
Kimberly-Clark
KMB
$36.6B
$2.46M 0.12%
17,900
+8,900
+99% +$1.2M
AAP icon
164
Advance Auto Parts
AAP
$2.63B
$2.46M 0.12%
15,351
+1,217
+9% +$195K
NFLX icon
165
CALL
Netflix
NFLX
$332B
$2.46M 0.12%
76,000
+44,000
+138% +$1.3M
CAG icon
166
Conagra Brands
CAG
$7.69B
$2.44M 0.12%
+71,404
New +$2.07M
IONS icon
167
PUT
Ionis Pharmaceuticals
IONS
$10.4B
$2.43M 0.12%
40,300
BIIB icon
168
CALL
Biogen
BIIB
$32.7B
$2.43M 0.12%
8,200
+5,200
+173% +$1.44M
CTSH icon
169
PUT
Cognizant
CTSH
$28.7B
$2.39M 0.12%
38,500
+35,300
+1,103% +$2.18M
CLX icon
170
CALL
Clorox
CLX
$12.5B
$2.38M 0.12%
+15,500
New +$2.32M
ADBE icon
171
CALL
Adobe
ADBE
$115B
$2.37M 0.12%
+7,200
New +$2.12M
STZ icon
172
CALL
Constellation Brands
STZ
$22.4B
$2.37M 0.12%
+12,500
New +$2.36M
STZ icon
173
PUT
Constellation Brands
STZ
$22.4B
$2.37M 0.12%
+12,500
New +$2.36M
K
174
PUT
DELISTED
Kellanova
K
$2.34M 0.11%
+35,997
New +$2.18M
STZ icon
175
Constellation Brands
STZ
$22.4B
$2.32M 0.11%
+12,251
New +$2.31M

Similar funds

Centiva Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Centiva Capital held 994 positions worth $2.05B, up 25% from $1.64B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Centiva Capital deployed $70.8M of net new capital in Q4 2019, opening 395 new positions and adding to 156 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 882,894 shares worth $146M.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 75% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $18.4M trimmed.

  • Centiva Capital's largest Q4 2019 buy was iShares Russell 2000 ETF: 882,894 shares worth $146M.
  • Centiva Capital added most to Wright Medical Group Inc in Q4 2019, an estimated $9.08M increase.
  • Centiva Capital's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $18.4M.
  • Centiva Capital fully exited Altaba Inc in Q4 2019, selling an estimated $93.3M.
  • Centiva Capital's ten largest holdings make up 28% of its $2.05B portfolio in Q4 2019.
  • Centiva Capital opened 395 new positions and closed 202 in Q4 2019.
  • Centiva Capital's portfolio value rose 25% quarter-over-quarter to $2.05B.

Based on Centiva Capital's 13F filing for Q4 2019, filed 14 Feb 2020.